U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2012
595
Name Type Language
TALIGLUCERASE ALFA
DASH   INN   MI   ORANGE BOOK   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
Taliglucerase alfa [WHO-DD]
Common Name English
TALIGLUCERASE ALFA [ORANGE BOOK]
Common Name English
PRGCD
Code English
TALIGLUCERASE ALFA [USAN]
Common Name English
UPLYSO
Brand Name English
TALIGLUCERASE ALFA [VANDF]
Common Name English
PRX-112
Code English
taliglucerase alfa [INN]
Common Name English
TALIGLUCERASE ALFA [MI]
Common Name English
ELELYSO
Brand Name English
PRGC-D
Code English
L-GLUTAMYL-L-PHENYLALANYL-(495(497)-L-HISTIDINE(R>H))HUMAN GLUCOSYLCERAMIDASE (BETA-GLUCOCEREBROSIDASE) PEPTIDE WITH L-ASPARTYL-L-LEUCYL-L-LEUCYL-L-VALYL-L-ASPARTYL-L-THREONYL-L-METHIONINE, GLYCOSYLATED PEPTIDE 1-506
Common Name English
Classification Tree Code System Code
WHO-VATC QA16AB11
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
FDA ORPHAN DRUG 191004
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
NCI_THESAURUS C29726
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
EMA ASSESSMENT REPORTS ELELYSO (REFUSED: GAUCHER DISEASE)
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
NDF-RT N0000175820
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
WHO-ATC A16AB11
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
EU-Orphan Drug EU/3/10/726
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
Code System Code Type Description
DAILYMED
0R4NLX88O4
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
PRIMARY
USAN
WW-100
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
PRIMARY
CAS
1005808-93-4
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
PRIMARY
RXCUI
1291609
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
PRIMARY RxNorm
IUPHAR
7444
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
PRIMARY
MERCK INDEX
m10439
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
PRIMARY Merck Index
EVMPD
SUB31580
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
PRIMARY
LACTMED
Taliglucerase alfa
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
PRIMARY
INN
9082
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
PRIMARY
DRUG CENTRAL
5199
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
PRIMARY
ChEMBL
CHEMBL1964120
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
PRIMARY
FDA UNII
0R4NLX88O4
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
PRIMARY
DRUG BANK
DB08876
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
PRIMARY
NCI_THESAURUS
C97411
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
PRIMARY
CAS
37228-64-1
Created by admin on Sat Dec 16 15:57:10 GMT 2023 , Edited by admin on Sat Dec 16 15:57:10 GMT 2023
GENERIC (FAMILY)
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966